{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:39:58Z","timestamp":1773117598151,"version":"3.50.1"},"reference-count":38,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Purpose: Tumor location influences survival in bladder cancer, potentially due to genetic heterogeneity driven by distinct embryological origins and structural compositions. We investigate location-specific somatic gene alterations (GAs) and their potential clinical implications in muscle-invasive bladder cancer (MIBC). Methods: We explored the role of the intra-bladder tumor location in determining survival and underlying genetic alterations in MIBC patients using multiple large independent databases. We analyzed the tumor location\u2019s impact on survival using the Surveillance, Epidemiology, and End Results (SEER) database and validated these findings using cBioPortal (CBP), which also contains gene sequencing data, enabling a comparison of GA frequency by tumor location. We investigated GA combinations to identify potential synthetic lethal (SL) combinations and co-occurrence signatures for survival prediction. Using the ROC Plotter database, we explored how significantly altered genes affect the response to immune checkpoint inhibitors (ICI). Results: An analysis of 6712 SEER and 570 CBP patients revealed significant (p &lt; 0.001) differences in overall survival stratified by tumor location, with trigone tumors showing the worst survival. Genomic analysis identified 35 genes with location-specific alteration frequencies. Three of these genes, CDKN2A, SPTAN1, and BIRC6, were significantly predictive of ICI response, and three genes were uniquely associated with a specific location: BPTF (anterior wall), RYR1, and OBSCN (dome). Furthermore, we identified 349 SL pairs from the 35 significantly altered genes, and a co-occurrence analysis revealed two novel gene pairs associated with improved survival. Conclusions: Intra-bladder tumor location determines survival and distinct genetic profiles in MIBC. These location-specific alterations predict ICI response and identify novel synthetic lethal targets, guiding precision oncology.<\/jats:p>","DOI":"10.3390\/cancers18050875","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:49:42Z","timestamp":1773071382000},"page":"875","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Spatial Heterogeneity in Muscle-Invasive Bladder Cancer on Overall Survival and Immunotherapy Response"],"prefix":"10.3390","volume":"18","author":[{"given":"Arjun","family":"Venkatesh","sequence":"first","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"},{"name":"School of Medicine, St. George\u2019s University, St. George P.O. Box 7, Grenada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7060-0027","authenticated-orcid":false,"given":"Reynier D.","family":"Rodriguez Rosales","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Kanumuambidi","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudai","family":"Ishiyama","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al-Toubat","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter","family":"Sceats","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Metzner","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8418-0924","authenticated-orcid":false,"given":"Shelby","family":"Sparks","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Murray","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3940-3275","authenticated-orcid":false,"given":"Mark","family":"Bandyk","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. C.","family":"Balaji","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Florida Jacksonville, Jacksonville, FL 32209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.euo.2018.08.018","article-title":"Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study","volume":"2","author":"Weiner","year":"2019","journal-title":"Eur. Urol. Oncol."},{"key":"ref_2","first-page":"531.e1","article-title":"Effect of Tumor Location on Survival in Urinary Bladder Adenocarcinoma: A Population-Based Analysis","volume":"34","author":"Dutta","year":"2016","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1242\/dev.011270","article-title":"The Development of the Bladder Trigone, the Center of the Anti-Reflux Mechanism","volume":"134","author":"Viana","year":"2007","journal-title":"Development"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.juro.2009.08.107","article-title":"Endodermal Origin of Bladder Trigone Inferred From Mesenchymal-Epithelial Interaction","volume":"183","author":"Tanaka","year":"2010","journal-title":"J. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.diff.2018.08.004","article-title":"Development of the Human Bladder and Ureterovesical Junction","volume":"103","author":"Liaw","year":"2018","journal-title":"Differentiation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","article-title":"NCCN Guidelines\u00ae Insights: Bladder Cancer, Version 3.2024","volume":"22","author":"Flaig","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/dvdy.24247","article-title":"Heterogeneity in Vascular Smooth Muscle Cell Embryonic Origin in Relation to Adult Structure, Physiology, and Disease","volume":"244","author":"Pfaltzgraff","year":"2015","journal-title":"Dev. Dyn."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11640","DOI":"10.1038\/s41598-021-91142-1","article-title":"Confirming Putative Variants at \u22645% Allele Frequency Using Allele Enrichment and Sanger Sequencing","volume":"11","author":"Yan","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"baac075","DOI":"10.1093\/database\/baac075","article-title":"SLOAD: A Comprehensive Database of Cancer-Specific Synthetic Lethal Interactions for Precision Cancer Therapy via Multi-Omics Analysis","volume":"2022","author":"Guo","year":"2022","journal-title":"Database"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/s41401-023-01079-6","article-title":"Predictive Biomarkers of Immunotherapy Response with Pharmacological Applications in Solid Tumors","volume":"44","author":"Fekete","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.surg.2015.12.029","article-title":"ROC-Ing along: Evaluation and Interpretation of Receiver Operating Characteristic Curves","volume":"159","author":"Carter","year":"2016","journal-title":"Surgery"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41597-024-03327-8","article-title":"Analysis of AlphaMissense Data in Different Protein Groups and Structural Context","volume":"11","author":"Tordai","year":"2024","journal-title":"Sci. Data"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1111\/epi.18155","article-title":"Evaluating Novel in Silico Tools for Accurate Pathogenicity Classification in Epilepsy-associated Genetic Missense Variants","volume":"65","author":"Montanucci","year":"2024","journal-title":"Epilepsia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41431-024-01638-3","article-title":"Using Computational Approaches to Enhance the Interpretation of Missense Variants in the PAX6 Gene","volume":"32","author":"Andhika","year":"2024","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01.ju.0000132323.89037.73","article-title":"A Referral center\u2019s experience with transitional cell carcinoma misdiagnosed as interstitial cystitis","volume":"172","author":"Tissot","year":"2004","journal-title":"J. Urol."},{"key":"ref_16","first-page":"E126","article-title":"Structural Differences between the Bladder Dome and Trigone Revealed by mRNA Expression Analysis of Cold-cut Biopsies","volume":"108","author":"Burkhard","year":"2011","journal-title":"BJU Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.12659\/MSM.904406","article-title":"The Dome Wall of Bladder Acts as a Pacemaker Site in Detrusor Instability in Rats","volume":"23","author":"Yu","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/PAP.0000000000000268","article-title":"Molecular Genetic Features of Primary Nonurachal Enteric-Type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia\/Adenoma: Review of the Literature and Next-Generation Sequencing Study","volume":"27","author":"Martinek","year":"2020","journal-title":"Adv. Anat. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.biomaterials.2008.09.034","article-title":"Regional Biomechanical and Histological Characterisation of the Passive Porcine Urinary Bladder: Implications for Augmentation and Tissue Engineering Strategies","volume":"30","author":"Korossis","year":"2009","journal-title":"Biomaterials"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1242\/jcs.009415","article-title":"RyR1-Specific Requirement for Depolarization-Induced Ca2+ Sparks in Urinary Bladder Smooth Muscle","volume":"120","author":"Fritz","year":"2007","journal-title":"J. Cell Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"16113","DOI":"10.1038\/s41598-022-19905-y","article-title":"The Ryanodine Receptor Mutational Characteristics and Its Indication for Cancer Prognosis","volume":"12","author":"Wang","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2021.11.016","article-title":"Giant Obscurin Regulates Migration and Metastasis via RhoA-Dependent Cytoskeletal Remodeling in Pancreatic Cancer","volume":"526","author":"Tuntithavornwat","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1038\/onc.2014.358","article-title":"Loss of Giant Obscurins from Breast Epithelium Promotes Epithelial-to-Mesenchymal Transition, Tumorigenicity and Metastasis","volume":"34","author":"Shriver","year":"2015","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.18632\/aging.101520","article-title":"Circ-BPTF Promotes Bladder Cancer Progression and Recurrence through the miR-31-5p\/RAB27A Axis","volume":"10","author":"Bi","year":"2018","journal-title":"Aging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00432-024-05632-6","article-title":"Advances in the Antitumor Mechanisms of Tripartite Motif-Containing Protein 3","volume":"150","author":"Teng","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12015-022-10444-7","article-title":"METTLing in Stem Cell and Cancer Biology","volume":"19","author":"Tooley","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s43141-022-00343-2","article-title":"The NDUFV2 Gene Silencing Inhibits the Proliferation of Two Drug-Resistant Cancer Cell Lines","volume":"20","author":"Liu","year":"2022","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13902","DOI":"10.1021\/acs.jmedchem.1c01294","article-title":"New Design Rules for Developing Potent Cell-Active Inhibitors of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition","volume":"64","author":"Zahid","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.21.02767","article-title":"Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion","volume":"40","author":"Chakravarty","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-025-01732-z","article-title":"The Role of Neoantigens and Tumor Mutational Burden in Cancer Immunotherapy: Advances, Mechanisms, and Perspectives","volume":"18","author":"Sun","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"14383","DOI":"10.1038\/s41598-018-32569-x","article-title":"CDKN2A as Transcriptomic Marker for Muscle-Invasive Bladder Cancer Risk Stratification and Therapy Decision-Making","volume":"8","author":"Worst","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"16642","DOI":"10.1038\/s41598-022-21158-8","article-title":"Targeted-Sequence of Normal Urothelium and Tumor of Patients with Non-Muscle Invasive Bladder Cancer","volume":"12","author":"Hayashi","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1038\/s41598-021-99524-1","article-title":"CDKN2A Loss-of-Function Predicts Immunotherapy Resistance in Non-Small Cell Lung Cancer","volume":"11","author":"Gutiontov","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"19563","DOI":"10.1038\/s41598-023-44028-3","article-title":"Tumor Microenvironment Heterogeneity in Bladder Cancer Identifies Biologically Distinct Subtypes Predicting Prognosis and Anti-PD-L1 Responses","volume":"13","author":"Li","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Dong, Y., Zheng, M., Wang, X., Yu, C., Qin, T., and Shen, X. (2023). High Expression of CDKN2A Is Associated with Poor Prognosis in Colorectal Cancer and May Guide PD-1-Mediated Immunotherapy. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11603-w"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cheng, T., Wu, Y., Liu, Z., Yu, Y., Sun, S., Guo, M., Sun, B., and Huang, C. (2022). CDKN2A-Mediated Molecular Subtypes Characterize the Hallmarks of Tumor Microenvironment and Guide Precision Medicine in Triple-Negative Breast Cancer. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.970950"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Schrecker, C., Behrens, S., Sch\u00f6nherr, R., Ackermann, A., Pauli, D., Plotz, G., Zeuzem, S., and Brieger, A. (2021). SPTAN1 Expression Predicts Treatment and Survival Outcomes in Colorectal Cancer. Cancers, 13.","DOI":"10.3390\/cancers13143638"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021038714","article-title":"A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets","volume":"31","author":"Wu","year":"2021","journal-title":"Crit. Rev. Eukaryot. Gene Expr."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/875\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:03:51Z","timestamp":1773072231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18050875"],"URL":"https:\/\/doi.org\/10.3390\/cancers18050875","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}